Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
Soo Ki Kim, Ke Ih Kim, Soo Ryang Kim
openalex +2 more sources
Macrophage inhibition in the alleviation of nonalcoholic steatohepatitis caused by bariatric surgery. [PDF]
Zheng Q, Deng S, Chen X, Wang Y, Yang Y.
europepmc +1 more source
Correction: De Novo Cost‑Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation. [PDF]
Gal P +7 more
europepmc +1 more source
Burden and trends of nonalcoholic steatohepatitis-related liver cancer in China: A population-based observational study using GBD 2021 data. [PDF]
Xiang MX, Yan P, Lan B, Deng JB, Tan J.
europepmc +1 more source
Enavogliflozin, an SGLT2 Inhibitor, Improves Nonalcoholic Steatohepatitis Induced by High-Fat, High-Cholesterol Diet. [PDF]
Pham PTM +7 more
europepmc +1 more source
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis [PDF]
Kanji Yamaguchi +9 more
openalex +1 more source
Punicalagin relieves hepatic injury by antioxidation and enhancement of autophagy in diet-induced nonalcoholic steatohepatitis. [PDF]
Ma L, Sun H, Xiang N, Xu Q.
europepmc +1 more source
Network pharmacology-based investigation of the pharmacological mechanisms of diosgenin in nonalcoholic steatohepatitis. [PDF]
Gu P +7 more
europepmc +1 more source
Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis
Yuji Ogawa +14 more
openalex +2 more sources

